An NK-like CAR T cell transition in CAR T cell dysfunctionCharly R. Good, Carl H. June, Lifeng Tian et al.|Cell|2021Cited by 398
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell DysfunctionNathan Singh, Marco Ruella, Yong Gu Lee et al.|Cancer Discovery|2020Cited by 297
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cellsSangya Agarwal, Carl H. June, M. Ángela Aznar et al.|Immunity|2023Cited by 164
Clinical and molecular dissection of CAR T cell resistance in pancreatic cancerM. Ángela Aznar, Mark H. O’Hara, Charly R. Good et al.|Cell Reports Medicine|2025Cited by 12
237 Enhancing mesothelin-directed CAR T cell therapy for unresectable or metastatic pancreatic adenocarcinomaM. Gómez, Mark H. O’Hara, Charly R. Good et al.|Regular and Young Investigator Award Abstracts|2024Cited by 1